Last Updated: 03/14/2015 05:55:13
DBD Stock Chart - 1 Month
DBD Stock Chart - 3 Month
DBD Stock Chart - 6 Month
DBD Stock Chart - 1 Year
DBD Stock Chart - 2 Year
What's Unfolding at OppFi? Mark your calendars, folks. October 28th is the day OppFi (NYSE: OPFI) pulls the curtain back on its third-quarter 2026 earnings. For the uninitiated, we're talking about a tech-driven finance platform that's been making waves by providing financial solutions for everyday Americans. And you bet we're all ears for what those numbers say. Details...
Continue Reading
Leadership Shake-up at JELD-WEN Alright, folks, the boardroom saga over at JELD-WEN just took another spin. Samantha Stoddard, the brain behind the numbers as Chief Financial Officer, is packing her bags come mid-November. Yeah, she's off to chase new horizons outside the realm of building products, leaving a spot hotter than a New York Stock Exchange ring bell up for...
Continue Reading
The DOCS Predicament: Investors Facing Class Action Doximity, Inc., trading as NYSE:DOCS, finds itself in hot water again as shareholders gear up for a legal skirmish over alleged securities fraud. Schall, Brown & Schwartz LLP, the firm rallying the shareholders, has fired the opening salvo, pointing fingers at Doximity for cooking the books about their Newsfeed’s...
Continue Reading
Saluting a Veteran's Advocate Amidst a world obsessed with bottom lines and market swings, it’s refreshing to spotlight someone like Sarah R. Weede. She's not about the Wall Street grind but you better believe her drive and dedication rival any big-shot CEO. Leadership in Veterans Services Sarah Weede's story starts with substantial roots planted in serving those who...
Continue Reading
The Harsh Reality Behind Artificial Stone You're slicing into your steak at a fancy dinner, and for a moment, you marvel at the countertop beneath your dish—a smooth, sleek surface that's likely made of artificial stone. But beneath that lustrous facade lurks a silent killer affecting those fabricating these countertops every day. Voices from the Frontline Recently,...
Continue Reading
New Era for B2B Sales Teams Once again, the B2B sales landscape is getting a jolt—especially for those who’ve been fumbling in the dark pitching to prospects without any real idea of their tech environment. With the introduction of Firmable's Tech Intelligence, those blind days just got a lot brighter. By offering detailed insights into what technologies a company is...
Continue Reading
Ryan Stills: A Comeback Story for the Ages Ryan Stills isn't just lifting weights; he's lifting the entire perception of what's possible after a heavy surgical setback. We're talking about a guy who stared down a hemi-shoulder replacement—a career ender for many—and came out the other side with a whole new set of gold medals. Two years ago, some might have written him...
Continue Reading
Collagen Solutions Front and Center First up, a little chat about collagen might be in order. For folks not tied into the science side, it sounds like a trendy wellness potion. But here comes GELITA at SupplySide Global 2026, showing it's the real McCoy. Nestled in Booth #4565, they're laying out a spread of next-gen collagen innovations aimed at everything from wound...
Continue Reading
Crucial Insights from the Convergence Conference Rich with intrigue, the privacy and AI governance game just upped its stakes. If there ever was a time to listen closely, it's now, people. With over 150 laws sprouting up faster than weeds, businesses are getting squeezed to keep their artificial ducks in a row. Last month over in New York, some big names in law and...
Continue Reading
Pushing the Boundaries with AI in Drug Discovery It seems some smart folks over in South Korea are giving the pharma game a fresh twist, pitting artificial intelligence against viral invaders in a newfangled brawl. Professors from Korea University have managed to blend AI's computing prowess with good ol' lab doggedness to sniff out potential antiviral compounds. The...
Continue Reading
Natural Remedies for Herpes Outbreaks In recent years, there has been an increasing interest in natural remedies to manage herpes outbreaks. As consumer awareness around health continues to evolve, the market for dietary supplements has expanded significantly, reaching a notable $1.23 billion. Amidst this backdrop, Herpafend has emerged as a key player, offering a unique...
Continue Reading
Introduction to Pivot Bio's Latest Innovation Pivot Bio is excited to announce the launch of its revolutionary product tailored specifically for cotton growers across the Cotton Belt. The introduction of CERT-N™ marks a significant advancement in agricultural technology, offering farmers an innovative tool to enhance their crop fertility management. About CERT-N™...
Continue Reading
Overview of The Bancorp, Inc. Investigation The Bancorp, Inc. (NASDAQ: TBBK) is currently the focus of a significant investigation into potential securities fraud. This probe has raised concerns among investors who may be eligible to recover losses stemming from the company’s financial disclosures. A recent announcement indicates that the corporation's financial...
Continue Reading
New Contract Awards by CEMATRIX Corporation CEMATRIX Corporation (TSX: CEMX) (OTCQB: CTXXF) is making headlines with its impressive announcement of securing $5.4 million in fresh contract awards. This notable achievement underscores CEMATRIX's robust reputation as a premier specialty construction contractor that excels in providing innovative cellular concrete solutions...
Continue Reading
Investors in Marqeta, Inc. Take Action Investors of Marqeta, Inc. (NASDAQ: MQ) have recently received important news regarding a class action lawsuit that serves as a beacon of hope for those who felt misled while investing in this promising technology company. Understanding the Class Action Lawsuit A class action lawsuit has been initiated against Marqeta, famed for its...
Continue Reading